vaccine, breast cancer

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...
A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial. The findings will be presented by ...
The samples are from patients across the country living with breast cancer. Knutson and his team work long hours in the cancer vaccine research lab, looking for answers to the same questions ...
Anixa Biosciences ( (ANIX) ) has provided an announcement. Anixa Biosciences, in collaboration with Cleveland Clinic, unveiled promising ...